Boyages John, Baker Lesley
Department of Clinical Medicine, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.
Radiation Oncology Associates and Genesis Cancer Care Pty Ltd., Macquarie University Hospital, Sydney, Australia.
Gland Surg. 2018 Dec;7(6):576-595. doi: 10.21037/gs.2018.11.10.
Radiation therapy (RT) is an important component of breast cancer treatment that reduces local recurrence and improves survival after breast conservation. Breast conservation rates have increased significantly since the late 1980s and techniques have improved with greater awareness of the impact of radiation on the heart. An overview of randomized controlled trials of breast conservation using standard whole breast irradiation, whole breast hypofractionation, accelerated partial breast irradiation (APBI) and intraoperative radiation are reviewed. Selection criteria for breast conservation and the utility of adding a boost dose to the primary tumor site are reviewed. Modern dose constraints are documented and 10 different radiation techniques from the 1980s through to modern volumetric modulated arc therapy (VMAT) are compared for a patient where the breast and internal mammary nodes are treated. A radiation boost reduces the risk of a recurrence for most, but not all patients. Short courses of RT over 3-4 weeks are generally as effective as longer courses. Short-term follow-up of trials of APBI show promise for selected good prognosis subgroups. The role of intraoperative radiation remains controversial. In the last 30 years, there have been significant advances in radiation techniques. Modern radiotherapy equipment and techniques will reduce complications and improve survival rates.
放射治疗(RT)是乳腺癌治疗的重要组成部分,可降低局部复发率并提高保乳术后的生存率。自20世纪80年代末以来,保乳率显著提高,随着对放疗对心脏影响的认识加深,技术也有所改进。本文综述了使用标准全乳照射、全乳低分割照射、加速部分乳腺照射(APBI)和术中放疗进行保乳的随机对照试验概况。还综述了保乳的选择标准以及在原发肿瘤部位增加推量剂量的效用。记录了现代剂量限制,并比较了从20世纪80年代到现代容积调强弧形放疗(VMAT)的10种不同放疗技术用于治疗乳腺和内乳淋巴结患者的情况。对于大多数但并非所有患者,放疗推量可降低复发风险。3 - 4周的短程放疗通常与长程放疗效果相同。APBI试验的短期随访显示,对于选定的预后良好亚组有前景。术中放疗的作用仍存在争议。在过去30年中,放疗技术取得了重大进展。现代放疗设备和技术将减少并发症并提高生存率。